We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TTNP market cap is 5.97M. The company's latest EPS is USD -6.0914 and P/E is -1.07.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 98k | 83k | 3k | 0 | 0 |
| Operating Income | -1.7M | -1.59M | -2.06M | -1.93M | -1.06M |
| Net Income | -1.68M | -1.59M | -338k | -1.97M | -1.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.61M | 4.84M | 1.53M | 557k | 184k |
| Operating Income | -16.84M | -7.35M | -9.35M | -10.24M | -7.28M |
| Net Income | -16.46M | -18.24M | -8.78M | -10.21M | -5.57M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.17M | 812k | 10M | 8.09M | 6.65M |
| Total Liabilities | 2.48M | 1.85M | 1.87M | 1.44M | 559k |
| Total Equity | -312k | -1.03M | 8.13M | 6.64M | 6.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.52M | 8.09M | 7.99M | 4.06M | 8.09M |
| Total Liabilities | 8.09M | 4.56M | 2.86M | 2.7M | 1.44M |
| Total Equity | 1.43M | 3.53M | 5.14M | 1.36M | 6.64M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.9M | -3.01M | -4.85M | -7.09M | -613k |
| Investing | N/A | N/A | 228k | 732k | N/A |
| Financing | N/A | N/A | 9.59M | 10M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.45M | -17.2M | -7.9M | -8.18M | -7.09M |
| Investing | -256k | -540k | -23k | N/A | 732k |
| Financing | 11.77M | 17.93M | 8.84M | 4.98M | 10M |
| Market Cap | 5.97M |
| Price to Earnings Ratio | -1.07 |
| Price to Sales Ratio | 32.39 |
| Price to Cash Ratio | 0.88 |
| Price to Book Ratio | 0.9 |
| Dividend Yield | - |
| Shares Outstanding | 914.23k |
| Average Volume (1 week) | 45.68k |
| Average Volume (1 Month) | 10.46k |
| 52 Week Change | -49.81% |
| 52 Week High | 14.56 |
| 52 Week Low | 5.00 |
| Spread (Intraday) | 5.09 (45.69%) |
| Company Name | Titan Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.titanpharm.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
